Monday, March 04, 2013 10:43:59 PM
All very true. However in the US, there is NO OTC Ibuprofen gel available and this would be the first of its kind - question is which Antares delivery system will be used.
Tappy mentioned the clinical trials capital expense by PFE as $30 million. I have also heard the same number (from an unnamed, reliable, double secret undisclosed source). I'm curious as to what that could translate to, as far as fees for a partner. Albeit, as biopete noted, Antares is not doing the heavy lifting, but their delivery technology is behind it - or to put it another way, making it possible.
Also, shadowplay mentioned something that I've thought about as well, and that's the "end" of the known agreement language of 3yrs post launch. What happens after that? This could be a two tranche agreement in the wings, a renegotiation when sales, etc are determinable. The first tranche, we know exists. Is there a second? Entirely possible. Or if not, then given the 3 yr lifespan, what's the size of the final payment upon successful conclusion to compensate Antares for use of their delivery system for infinity?
jab9
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM